A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder
Abstract Background Long-term treatment is recommended in major depressive disorder (MDD) to prevent relapse and to restore functioning. The aim